D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
IGMS holding history
IGM Biosciences, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
IGMS overviewAll 13F holders of IGMSFull Q2 2026 holdings
- Shares (Q1 2025)
- 0
- Sold out in Q1 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 16
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 0 | $0 | 0.0% | −10,107−100.0% | Sold out | Holders |
| Q4 2024 | 10,107 | $61.8K | <0.1% | −87,609−89.7% | Reduced | Holders |
| Q3 2024 | 97,716 | $1.62M | <0.1% | −33,349−25.4% | Reduced | Holders |
| Q2 2024 | 131,065 | $900.4K | <0.1% | +37,902+40.7% | Added | Holders |
| Q1 2024 | 93,163 | $899.0K | <0.1% | +45,918+97.2% | Added | Holders |
| Q4 2023 | 47,245 | $392.6K | <0.1% | −28,669−37.8% | Reduced | Holders |
| Q3 2023 | 75,914 | $633.9K | <0.1% | −99,672−56.8% | Reduced | Holders |
| Q2 2023 | 175,586 | $1.62M | <0.1% | −148,951−45.9% | Reduced | Holders |
| Q1 2023 | 324,537 | $4.46M | <0.1% | −65,349−16.8% | Reduced | Holders |
| Q4 2022 | 389,886 | $6.63M | <0.1% | +52,716+15.6% | Added | Holders |
| Q3 2022 | 337,170 | $7.67M | <0.1% | +62,616+22.8% | Added | Holders |
| Q2 2022 | 274,554 | $4.95M | <0.1% | −111,158−28.8% | Reduced | Holders |
| Q1 2022 | 385,712 | $10.3M | <0.1% | +253,614+192.0% | Added | Holders |
| Q4 2021 | 132,098 | $3.87M | <0.1% | +116,413+742.2% | Added | Holders |
| Q3 2021 | 15,685 | $1.03M | <0.1% | −11,675−42.7% | Reduced | Holders |
| Q2 2021 | 27,360 | $2.28M | <0.1% | −28,331−50.9% | Reduced | Holders |
| Q1 2021 | 55,691 | $4.27M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.